Pardieu, Bryann
Pasanisi, Justine
Ling, Frank
Dal Bello, Reinaldo
Penneroux, Justine
Su, Angela
Joudinaud, Romane
Chat, Laureen
Wu, Hsin Chieh
Duchmann, Matthieu
Sodaro, Gaetano
Chauvel, Clémentine
Castelli, Florence A.
Vasseur, Loic
Pacchiardi, Kim
Belloucif, Yannis http://orcid.org/0000-0001-6364-4098
Laiguillon, Marie-Charlotte
Meduri, Eshwar
Vaganay, Camille
Alexe, Gabriela http://orcid.org/0000-0002-5668-6297
Berrou, Jeannig
Benaksas, Chaima
Forget, Antoine
Braun, Thorsten
Gardin, Claude
Raffoux, Emmanuel
Clappier, Emmanuelle
Adès, Lionel http://orcid.org/0000-0002-9020-8766
de Thé, Hugues http://orcid.org/0000-0002-1113-4472
Fenaille, François http://orcid.org/0000-0001-6787-4149
Huntly, Brian J. http://orcid.org/0000-0003-0312-161X
Stegmaier, Kimberly http://orcid.org/0000-0003-0218-7895
Dombret, Hervé
Fenouille, Nina
Lobry, Camille http://orcid.org/0000-0003-0550-4921
Puissant, Alexandre http://orcid.org/0000-0002-3997-9282
Itzykson, Raphael http://orcid.org/0000-0003-2139-6262
Article History
Received: 12 October 2021
Revised: 1 April 2022
Accepted: 7 April 2022
First Online: 26 April 2022
Competing interests
: The authors have no conflicts of interest to disclose. RI has consulted for Abbvie, Amgen, BMS/Celgene, Daiichi-Sankyo, Jazz Pharma, Karyopharm, Novartis and Stemline Therapeutics, and received research funding from Novartis and Janssen, none of which is related to the present work. KS has consulted for Kronos Bio, Auron Therapeutics, and Astra-Zeneca on unrelated topics, receives grant funding from Novartis which did not fund this project, and holds stock options with Auron Therapeutics on unrelated topics.